Highlights
- 1Science advances · 2024
- 2Journal of medicinal chemistry · 2025
Publications
8 publications
Funding
3 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- PIR21AI193472-01A1Combining host and pathogen-directed approaches to kill Mtb by exploiting its dependence on cholesterol metabolismNational Institute of Allergy and Infectious Diseases · 2026–2028
- Co-IP01AI159402-01Transmission Aerobiology of M. tuberculosis: Genes and Metabolic Pathways That Sustain Mtb Across an Evolutionary BottleneckNational Institute of Allergy and Infectious Diseases · 2021–2027
Completed grants (1)
- KPINV-040480Phosphopantetheinyl transferase (PptT) inhibitors for treatment of TB- INV-040480Bill & Melinda Gates Foundation · 2022–2024